Conmed (CNMD) Gross Margin (2010 - 2026)
Conmed's (CNMD) quarterly Gross Margin came in at 57.49% in Q2 2026, up 248.0% on a YoY basis from 16.52% in Q2 2025, and down 0.65% quarter-over-quarter from 57.86% in Q1 2026.
Powered by 
Analysis
Conmed (CNMD) Gross Margin (2010 - 2026) Analysis & Trends
Conmed (CNMD) has reported Gross Margin for 17 consecutive years, with 57.49% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Gross Margin rose 248.0% year-over-year to 57.49%; the trailing twelve-month figure through Jun 2026 stood at 55.79% (down 26.0% YoY), and the FY2025 full-year result was 54.59%, down 149.0% from the prior year.
- Gross Margin eased to 57.49% in Q2 2026 per CNMD's latest filing, from 57.86% in the prior quarter.
- Across five years, Gross Margin topped out at 58.49% in Q4 2025 and bottomed at 49.16% in Q3 2025.
- Historically, Gross Margin has averaged 55.18% across 5 years, with a median of 55.25% in 2023.
- The sharpest annual moves came in 2023 and 2025: Gross Margin soared 314 bps in 2023, then slumped 736 bps in 2025.
- Over 5 years, Gross Margin stood at 52.56% in 2022, then gained by 6 bps to 55.7% in 2023, then increased by 3 bps to 57.33% in 2024, then climbed by 2 bps to 58.49% in 2025, then declined by 2 bps to 57.49% in 2026.
- According to Business Quant data, Gross Margin over the past three periods registered 57.49%, 57.86%, and 58.49% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 57.71% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 67.78% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 64.99% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 68.27% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 70.71% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 77.46% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 60.21% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 63.44% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | 45.84% |
| 10 | Conmed | 1.42 Bn | 1.38 Bn | 197.46 Mn | 57.49% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 57.49% |
| Mar 31, 2026 | 57.86% |
| Dec 31, 2025 | 58.49% |
| Sep 30, 2025 | 49.16% |
| Jun 30, 2025 | 55.01% |
| Mar 31, 2025 | 55.33% |
| Dec 31, 2024 | 57.33% |
| Sep 30, 2024 | 56.52% |
| Jun 30, 2024 | 55.32% |
| Mar 31, 2024 | 55.07% |
| Dec 31, 2023 | 55.70% |
| Sep 30, 2023 | 55.18% |
| Jun 30, 2023 | 53.73% |
| Mar 31, 2023 | 52.57% |
| Dec 31, 2022 | 52.56% |
| Sep 30, 2022 | 55.12% |
| Jun 30, 2022 | 54.76% |
| Mar 31, 2022 | 56.12% |
| Dec 31, 2021 | 56.89% |
| Sep 30, 2021 | 57.19% |